Funded Tech Companies
Lysoway Therapeutics
Operating out of Cambridge, Lysoway Therapeutics has funding from The Michael J. Fox Foundation for Parkinson's Research.
Company Overview
Company Name
Lysoway Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
245 1st Street 1800
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Lysoway Therapeutics is pioneering the field of lysosomal ion-channel biology and next-generation drug discovery. Using our proprietary screening platforms and structure-guided design technologies, we develop highly brain-penetrant, selective, and potent small-molecule modulators targeting key lysosomal ion channels such as TRPML1 and TMEM175. These ion channels are essential regulators of intracellular signaling and play a central role in maintaining lysosomal health and autophagic flux--critical processes that often break down in age-related neurodegenerative diseases and lysosomal storage disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/1/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yongchang Qiu
Vice President
Junsheng Yang
VP - Bus. Development
Xiang Yu
VP - R & D
Valerie Cullen
Company Investors
- The Michael J. Fox Foundation for Parkinson's Research (Jessica Garcia)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs